Profile
| Role | Insider |
|---|---|
| Notability | 30/100 |
Updated Jul 16, 2026
Dolsten Mikael has filed 3 SEC Form 4 filings across 3 companies in the last 90 days — selling. Lifetime open-market sales: $217K.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-06 | RCKT | ROCKET PHARMACEUTICALS, INC. | A — Grant or award | 22.9K | $0.00 | |
| 2026-06-02 | A | AGILENT TECHNOLOGIES, INC. | S — Open-market sale | 1.6K | $135.42 | $217K |
| 2026-05-14 | APLS | Apellis Pharmaceuticals, Inc. | D — Derivative transaction | 14.3K | — | |
| 2026-05-14 | APLS | Apellis Pharmaceuticals, Inc. | J — Other acquisition / disposition | 14.3K | — | |
| 2026-03-23 | A | AGILENT TECHNOLOGIES, INC. | A — Grant or award | 2.2K | $111.75 | $241K |
| 2026-03-03 | APLS | Apellis Pharmaceuticals, Inc. | A — Grant or award | 14.3K | $0.00 | |
| 2025-06-18 | RCKT | ROCKET PHARMACEUTICALS, INC. | A — Grant or award | 30.0K | $0.00 | |
| 2025-03-05 | RCKT | ROCKET PHARMACEUTICALS, INC. | J — Other acquisition / disposition | 14.2K | $0.00 |
Dolsten Mikael is a corporate insider — currently tracked as Insider of ROCKET PHARMACEUTICALS, INC. (RCKT). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 3 companies.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($217K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Dolsten Mikael profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.